Shining the light on clinical application of mesenchymal stem cell therapy in autoimmune diseases

被引:0
作者
Saade Abdalkareem Jasim
Alexei Valerievich Yumashev
Walid Kamal Abdelbasset
Ria Margiana
Alexander Markov
Wanich Suksatan
Benjamin Pineda
Lakshmi Thangavelu
Seyed Hossein Ahmadi
机构
[1] Al-Maarif University College,Medical Laboratory Techniques Department
[2] Department of Prosthetic Dentistry,Department of Health and Rehabilitation Sciences, College of Applied Medical Sciences
[3] Sechenov First Moscow State Medical University,Department of Physical Therapy, Kasr Al
[4] Prince Sattam Bin Abdulaziz University,Aini Hospital
[5] Cairo University,Department of Anatomy, Faculty of Medicine
[6] Universitas Indonesia,Master’s Programme Biomedical Sciences, Faculty of Medicine
[7] Universitas Indonesia,Faculty of Nursing, HRH Princess Chulabhorn College of Medical Science
[8] Dr. Soetomo General Academic Hospital,Department of Neuroimmunology
[9] Tyumen State Medical University,Center for Transdisciplinary Research ,Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Science
[10] Industrial University,Cellular and Molecular Research Center, School of Medicine
[11] Chulabhorn Royal Academy,undefined
[12] National Institute of Neurology and Neurosurgery “Manuel Velasco Suarez” (INNN),undefined
[13] 14269,undefined
[14] Saveetha University,undefined
[15] Tehran University of Medical Sciences,undefined
来源
Stem Cell Research & Therapy | / 13卷
关键词
Mesenchymal stromal cell; Autoimmune diseases; Stem cell therapy; Clinical application;
D O I
暂无
中图分类号
学科分类号
摘要
The autoimmune diseases are associated with the host immune system, chronic inflammation, and immune reaction against self-antigens, which leads to the injury and failure of several tissues. The onset of autoimmune diseases is related to unbalanced immune homeostasis. Mesenchymal stem cells (MSCs) are multipotent cells which have capability to self-renew and differentiate into various cell types that exert a critical role in immunomodulation and regenerative therapy. Under the certain condition in vitro, MSCs are able to differentiate into multiple lineage such as osteoblasts, adipocytes, and neuron-like cells. Consequently, MSCs have a valuable application in cell treatment. Accordingly, in this review we present the last observations of researches on different MSCs and their efficiency and feasibility in the clinical treatment of several autoimmune disorders including rheumatoid arthritis, type 1 diabetes, multiple sclerosis, systemic lupus erythematosus, inflammatory bowel disease, autoimmune liver disease, and Sjogren’s syndrome.
引用
收藏
相关论文
共 142 条
[1]  
Fugger L(2020)Challenges, progress, and prospects of developing therapies to treat autoimmune diseases Cell 181 63-80
[2]  
Jensen LT(2019)Biosensors and nanobiosensors for rapid detection of autoimmune diseases: a review Microchim Acta 186 838-71
[3]  
Rossjohn J(2014)A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn's disease refractory to biologic therapy Clin Gastroenterol Hepatol 12 64-1388
[4]  
Ghorbani F(1990)Autoimmune diseases: the failure of self tolerance Science 248 1380-121
[5]  
Forbes GM(2017)Immunosensors for biomarker detection in autoimmune diseases Arch Immunol Ther Exp (Warsz) 65 111-608
[6]  
Sinha AA(2017)Epigenetic modifications and epigenetic based medication implementations of autoimmune diseases Biomed Pharmacother 87 596-i66
[7]  
Lopez MT(2017)Pathways leading to an immunological disease: systemic lupus erythematosus Rheumatology (Oxford) 56 i55-135
[8]  
McDevitt HO(2001)Historical and current perspectives on bone marrow transplantation for prevention and treatment of immunodeficiencies and autoimmunities Biol Blood Marrow Transplant 7 123-176
[9]  
Zhang X(1999)Bone marrow transplantation as effective treatment of central nervous system disease in globoid cell leukodystrophy, metachromatic leukodystrophy, adrenoleukodystrophy, mannosidosis, fucosidosis, aspartylglucosaminuria, Hurler, Maroteaux-Lamy, and Sly syndromes, and Gaucher disease type III Curr Opin Neurol 12 167-256
[10]  
Ahmadi M(2017)Haematopoietic stem cell transplantation for autoimmune diseases Nat Rev Rheumatol 13 244-221